Matches in SemOpenAlex for { <https://semopenalex.org/work/W2155198744> ?p ?o ?g. }
- W2155198744 endingPage "1802" @default.
- W2155198744 startingPage "1783" @default.
- W2155198744 abstract "Emerging as an epidemic of the 21st century type 2 diabetes has become a major health problem throughout the globe. The number of deaths attributable to diabetes reflects the insufficient glycemic control achieved with the treatments used in recent past. DPP-4 inhibitors have been investigated as a new therapy with novel mechanisms of action and improved tolerability. DPP-4, a protease that specifically cleaves dipeptides from proteins and oligopeptides after a penultimate N-terminal proline or alanine, is involved in the degradation of a number of neuropeptides, peptide hormones and cytokines, including the incretins GLP-1 and GIP. As soon as released from the gut in response to food intake, GLP-1 and GIP exert a potent glucose-dependent insulinotropic action, thereby playing a key role in the maintenance of post-meal glycemic control. Consequently, inhibiting DPP-4 prolongs the action of GLP-1 and GIP, which in turn improves glucose homeostasis with a low risk of hypoglycemia and potential for disease modification. Indeed, clinical trials involving diabetic patients have shown improved glucose control by administering DPP-4 inhibitors, thus demonstrating the benefit of this promising new class of antidiabetics. Intense research activities in this area have resulted in the launch of sitagliptin and vildagliptin (in Europe only) and the advancement of a few others into preregistration/phase 3, for example, saxagliptin, alogliptin and ABT-279. Achieving desired selectivity for DPP-4 over other related peptidases such as DPP-8 and DPP-9 (inhibition of which was linked to toxicity in animal studies) and long-acting potential for maximal efficacy (particularly in more severe diabetic patients) were the major challenges. Whether these goals are achieved with the present series of inhibitors in the advanced stages of clinical development is yet to be confirmed. Nevertheless, treatment of this metabolic disorder especially in the early stages of the disease via DPP-4 inhibition has been recognized as a validated principle and a large number of inhibitors are presently in various stage of pre-clinical/clinical development. Sitagliptin is a new weapon in the arsenal of oral antihyperglycemic agents. This review will focus on the journey of drug discovery of DPP-4 inhibitors for oral delivery covering a brief scientific background and medicinal chemistry approaches along with the status of advanced clinical candidates." @default.
- W2155198744 created "2016-06-24" @default.
- W2155198744 creator A5041372158 @default.
- W2155198744 creator A5042652780 @default.
- W2155198744 date "2009-03-01" @default.
- W2155198744 modified "2023-10-18" @default.
- W2155198744 title "Medicinal chemistry approaches to the inhibition of dipeptidyl peptidase-4 for the treatment of type 2 diabetes" @default.
- W2155198744 cites W1964212912 @default.
- W2155198744 cites W1965799612 @default.
- W2155198744 cites W1968676703 @default.
- W2155198744 cites W1969041963 @default.
- W2155198744 cites W1975588287 @default.
- W2155198744 cites W1975767684 @default.
- W2155198744 cites W1976317419 @default.
- W2155198744 cites W1977471179 @default.
- W2155198744 cites W1977679840 @default.
- W2155198744 cites W1978902333 @default.
- W2155198744 cites W1980451564 @default.
- W2155198744 cites W1983345845 @default.
- W2155198744 cites W1986271091 @default.
- W2155198744 cites W1986626610 @default.
- W2155198744 cites W1989963909 @default.
- W2155198744 cites W1990755598 @default.
- W2155198744 cites W1991641597 @default.
- W2155198744 cites W1992603068 @default.
- W2155198744 cites W1993270448 @default.
- W2155198744 cites W1993287695 @default.
- W2155198744 cites W1995077775 @default.
- W2155198744 cites W1997400930 @default.
- W2155198744 cites W1998817071 @default.
- W2155198744 cites W1999488408 @default.
- W2155198744 cites W2001522771 @default.
- W2155198744 cites W2001650285 @default.
- W2155198744 cites W2011238752 @default.
- W2155198744 cites W2012437459 @default.
- W2155198744 cites W2018756266 @default.
- W2155198744 cites W2021298650 @default.
- W2155198744 cites W2021693796 @default.
- W2155198744 cites W2024944149 @default.
- W2155198744 cites W2025365430 @default.
- W2155198744 cites W2027725447 @default.
- W2155198744 cites W2028227158 @default.
- W2155198744 cites W2028707869 @default.
- W2155198744 cites W2032939032 @default.
- W2155198744 cites W2035972962 @default.
- W2155198744 cites W2037009206 @default.
- W2155198744 cites W2037026646 @default.
- W2155198744 cites W2039224608 @default.
- W2155198744 cites W2041585310 @default.
- W2155198744 cites W2041914199 @default.
- W2155198744 cites W2047270074 @default.
- W2155198744 cites W2047689001 @default.
- W2155198744 cites W2049222364 @default.
- W2155198744 cites W2049268367 @default.
- W2155198744 cites W2055903184 @default.
- W2155198744 cites W2064780710 @default.
- W2155198744 cites W2065759622 @default.
- W2155198744 cites W2066121036 @default.
- W2155198744 cites W2066472328 @default.
- W2155198744 cites W2068563471 @default.
- W2155198744 cites W2069835632 @default.
- W2155198744 cites W2071409044 @default.
- W2155198744 cites W2071789881 @default.
- W2155198744 cites W2073996229 @default.
- W2155198744 cites W2074151318 @default.
- W2155198744 cites W2078021048 @default.
- W2155198744 cites W2079847644 @default.
- W2155198744 cites W2080677146 @default.
- W2155198744 cites W2082082406 @default.
- W2155198744 cites W2084619910 @default.
- W2155198744 cites W2084948079 @default.
- W2155198744 cites W2086396795 @default.
- W2155198744 cites W2089089552 @default.
- W2155198744 cites W2092890426 @default.
- W2155198744 cites W2095095800 @default.
- W2155198744 cites W2104763836 @default.
- W2155198744 cites W2105152234 @default.
- W2155198744 cites W2108771199 @default.
- W2155198744 cites W2109157463 @default.
- W2155198744 cites W2109758717 @default.
- W2155198744 cites W2112852213 @default.
- W2155198744 cites W2116480916 @default.
- W2155198744 cites W2119265400 @default.
- W2155198744 cites W2129563718 @default.
- W2155198744 cites W2130429582 @default.
- W2155198744 cites W2130927032 @default.
- W2155198744 cites W2140373059 @default.
- W2155198744 cites W2141435766 @default.
- W2155198744 cites W2145884719 @default.
- W2155198744 cites W2146232529 @default.
- W2155198744 cites W2149794013 @default.
- W2155198744 cites W2150159032 @default.
- W2155198744 cites W2154383633 @default.
- W2155198744 cites W2155060077 @default.
- W2155198744 cites W2157635822 @default.
- W2155198744 cites W2159018914 @default.
- W2155198744 cites W2159205789 @default.
- W2155198744 cites W2160895888 @default.